Renaissance Technologies - REGULUS THERAPEUTICS INC ownership

Back to all holdings Add to watchlist

REGULUS THERAPEUTICS INC's ticker is and the CUSIP is 75915K309. A total of 29 filers reported holding REGULUS THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
Quarter-by-quarter ownership
Renaissance Technologies ownership history of REGULUS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$69
+1.5%
50,100
+8.7%
0.00%–
Q2 2023$68
+106.1%
46,100
+18.8%
0.00%–
Q1 2023$33
-31.2%
38,800
+11.5%
0.00%–
Q4 2022$48
-99.9%
34,800
+7.4%
0.00%–
Q3 2022$55,000
-5.2%
32,400
+15.3%
0.00%–
Q2 2022$58,000–28,100–0.00%–
 Download
Other shareholders
REGULUS THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 1,111,049$1,522,1370.47%
Sarissa Capital Management LP 185,183$253,7010.03%
FEDERATED HERMES, INC. 3,875,578$5,348,2980.01%
PRELUDE CAPITAL MANAGEMENT, LLC 40,260$55,1560.00%
Virtu Financial LLC 25,921$360.00%
GRIMES & COMPANY, INC. 10,547$14,4490.00%
ROYAL BANK OF CANADA 80$00.00%
VANGUARD GROUP INC 285,050$390,5190.00%
VICTORY CAPITAL MANAGEMENT INC 233,207$321,8260.00%
UBS Group AG 408$5580.00%
View complete list of REGULUS THERAPEUTICS INC shareholders